FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016287769> ?p ?o ?g. }

• W2016287769 endingPage "399" @default.
• W2016287769 startingPage "399" @default.
• W2016287769 abstract "Comments1 September 1976Hereditary Angioedema and Heparin TherapyROBERT W. COLMAN, M.D., F.A.C.P.ROBERT W. COLMAN, M.D., F.A.C.P.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-85-3-399 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor: Doctors Frank, Gelfand, and Atkinson have presented an impressive NIH Conference on hereditary angioedema (Ann Intern Med 84:580-593, 1976). They indicate that although long-term and short-term prophylaxis of attacks have been successful, specific therapy for acute attacks is not available. Kininogen, the substrate of kallikrein, is activated and decreases during an attack, (1, 2), suggesting that bradykinin formation may play a role in the pathogenesis of this disease. The mode of release of the C2-kinin (3) released during attacks of hereditary angioedema is not fully known, but the inhibition of its formation by soybean trypsin inhibitor suggests...References References References1. LANDERMANWEBSTERBECKER NME: Hereditary angioneurotic edema. II. Deficiency of inhibitor for serum globulin permeability factor and/or plasma kallikrein. J Allergy 33:330-341, 1962 CrossrefMedlineGoogle Scholar2. BURDONQUENGTHOMAS KJO: Observations on the biochemical abnormalities in hereditary angioneurotic edema. J Allergy 36:546-557, 1965 CrossrefMedlineGoogle Scholar3. DONALDSONRATNOFFDIASSILVA VODW: Permeability increasing activity in hereditary angioneurotic edema plasma. II. Mechanism of formation and partial characterization. J Clin Invest 48:642-653, 1969 CrossrefMedlineGoogle Scholar4. ROSENBERG R: The coagulation fibrinolytic mechanism and the action of heparin. Adv Exp Med Biol 52:217-238, 1974 CrossrefGoogle Scholar5. LAHIRIBAGDASARIANMITCHELL BAB: Antithrombinheparin cofactor: an inhibitor of plasma kallikrein. Arch Biochem Biophys, 1976, in press CrossrefMedlineGoogle Scholar1. REIMANN H: Periodic Diseases. Philadelphia, F. A. Davis Co., 1963, p. 72 Google Scholar2. REIMANN H: Hereditary periodic edema, in The Interrelation of Familial Periodic Disorders. Am J Med Sci 243:727-739, 1962 CrossrefMedlineGoogle Scholar3. REIMANN H: Rhythms and periodicity in health and disease. Ann Clin Lab Sci 5:417-420, 1975 MedlineGoogle Scholar4. WOLF N: Introductory remarks, rhythmic functions in living systems. Ann NY Acad Sci 98:753, 1962 Google Scholar5. BAILEY R: Periodic hormonogenesis—a new phenomenon. Periodicity in function of a hormone-producing tumor in man. J Clin Endocrinol Metab 32:317-327, 1971 CrossrefMedlineGoogle Scholar6. CHAJEKROMANOFF TH: Cushing syndrome with cyclical edema and periodic secretion of corticosteroids. Arch Intern Med 136:441-446, 1976 CrossrefMedlineGoogle Scholar1. DONALDSONRATNOFFDIASSILVA VODE: Permeability increasing activity in hereditary angioneurotic edema plasma. II. Mechanism of formation and partial characterization. J Clin Invest 48:642-653, 1969 CrossrefMedlineGoogle Scholar2. RENTERTELEISENSTEIN RNR: Complement activation by interaction of polyanions and polycations. I. Heparin-protamine induced consumption of complement. J Immunol 114:120-124, 1975 MedlineGoogle Scholar3. DONALDSONEVANS VR: A biochemical abnormality in hereditary angioneurotic edema. Am J Med 35:37-44, 1963 CrossrefMedlineGoogle Scholar4. OSLER W: Hereditary angioneurotic oedema. Am J Med Sci 95:362-367, 1888 CrossrefGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Hematology-Oncology Section Department of Medicine Hospital of the University of Pennsylvania Philadelphia, PA 19104 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byDoes heparin prophylaxis prevent exacerbations of hereditary angioedema?Acquired C1 Esterase Inhibitor DeficiencySvetomir N. Markovic, MD, PhD, David J. Inwards, MD, Evangelos A. Frigas, MD, and Robert P. Phyliky, MDHigh molecular weight kininogen potentiates the heparin-accelerated inhibition of plasma kallikrein by antithrombin: Role for antithrombin in the regulation of kallikreinParallel Procoagulant and Anticoagulant Pathways for High Molecular Weight Kininogen Coagulant FunctionTraitement de l'œdème angioneurotique héréditaireKallikrein-Kinin System in Pathologic Conditions 1 September 1976Volume 85, Issue 3Page: 399-400KeywordsHeparinHereditary angioedemaPathogenesisProphylaxis Issue Published: 1 September 1976 PDF downloadLoading ..." @default.
• W2016287769 created "2016-06-24" @default.
• W2016287769 creator A5069143752 @default.
• W2016287769 date "1976-09-01" @default.
• W2016287769 modified "2023-09-26" @default.
• W2016287769 title "Hereditary Angioedema and Heparin Therapy" @default.
• W2016287769 cites W1497280552 @default.
• W2016287769 cites W1509856372 @default.
• W2016287769 cites W1522956225 @default.
• W2016287769 cites W1574312885 @default.
• W2016287769 cites W1978451044 @default.
• W2016287769 cites W1978803451 @default.
• W2016287769 cites W1982216137 @default.
• W2016287769 cites W2026692182 @default.
• W2016287769 cites W2078264642 @default.
• W2016287769 cites W2281313324 @default.
• W2016287769 cites W85898938 @default.
• W2016287769 doi "https://doi.org/10.7326/0003-4819-85-3-399" @default.
• W2016287769 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/962234" @default.
• W2016287769 hasPublicationYear "1976" @default.
• W2016287769 type Work @default.
• W2016287769 sameAs 2016287769 @default.
• W2016287769 citedByCount "8" @default.
• W2016287769 countsByYear W20162877692013 @default.
• W2016287769 countsByYear W20162877692022 @default.
• W2016287769 crossrefType "journal-article" @default.
• W2016287769 hasAuthorship W2016287769A5069143752 @default.
• W2016287769 hasConcept C113045295 @default.
• W2016287769 hasConcept C126322002 @default.
• W2016287769 hasConcept C152328610 @default.
• W2016287769 hasConcept C170493617 @default.
• W2016287769 hasConcept C181199279 @default.
• W2016287769 hasConcept C185592680 @default.
• W2016287769 hasConcept C203014093 @default.
• W2016287769 hasConcept C2776246183 @default.
• W2016287769 hasConcept C2777167447 @default.
• W2016287769 hasConcept C2777557582 @default.
• W2016287769 hasConcept C2777788586 @default.
• W2016287769 hasConcept C2777995640 @default.
• W2016287769 hasConcept C2778382381 @default.
• W2016287769 hasConcept C2779591629 @default.
• W2016287769 hasConcept C2779931649 @default.
• W2016287769 hasConcept C2780886150 @default.
• W2016287769 hasConcept C2780942790 @default.
• W2016287769 hasConcept C2781221834 @default.
• W2016287769 hasConcept C52853521 @default.
• W2016287769 hasConcept C55493867 @default.
• W2016287769 hasConcept C71924100 @default.
• W2016287769 hasConceptScore W2016287769C113045295 @default.
• W2016287769 hasConceptScore W2016287769C126322002 @default.
• W2016287769 hasConceptScore W2016287769C152328610 @default.
• W2016287769 hasConceptScore W2016287769C170493617 @default.
• W2016287769 hasConceptScore W2016287769C181199279 @default.
• W2016287769 hasConceptScore W2016287769C185592680 @default.
• W2016287769 hasConceptScore W2016287769C203014093 @default.
• W2016287769 hasConceptScore W2016287769C2776246183 @default.
• W2016287769 hasConceptScore W2016287769C2777167447 @default.
• W2016287769 hasConceptScore W2016287769C2777557582 @default.
• W2016287769 hasConceptScore W2016287769C2777788586 @default.
• W2016287769 hasConceptScore W2016287769C2777995640 @default.
• W2016287769 hasConceptScore W2016287769C2778382381 @default.
• W2016287769 hasConceptScore W2016287769C2779591629 @default.
• W2016287769 hasConceptScore W2016287769C2779931649 @default.
• W2016287769 hasConceptScore W2016287769C2780886150 @default.
• W2016287769 hasConceptScore W2016287769C2780942790 @default.
• W2016287769 hasConceptScore W2016287769C2781221834 @default.
• W2016287769 hasConceptScore W2016287769C52853521 @default.
• W2016287769 hasConceptScore W2016287769C55493867 @default.
• W2016287769 hasConceptScore W2016287769C71924100 @default.
• W2016287769 hasIssue "3" @default.
• W2016287769 hasLocation W20162877691 @default.
• W2016287769 hasLocation W20162877692 @default.
• W2016287769 hasOpenAccess W2016287769 @default.
• W2016287769 hasPrimaryLocation W20162877691 @default.
• W2016287769 hasRelatedWork W110920918 @default.
• W2016287769 hasRelatedWork W1574872130 @default.
• W2016287769 hasRelatedWork W1973740388 @default.
• W2016287769 hasRelatedWork W1983969090 @default.
• W2016287769 hasRelatedWork W2093113446 @default.
• W2016287769 hasRelatedWork W2152793531 @default.
• W2016287769 hasRelatedWork W2429637832 @default.
• W2016287769 hasRelatedWork W3057476791 @default.
• W2016287769 hasRelatedWork W3095903883 @default.
• W2016287769 hasRelatedWork W2187026315 @default.
• W2016287769 hasVolume "85" @default.
• W2016287769 isParatext "false" @default.
• W2016287769 isRetracted "false" @default.
• W2016287769 magId "2016287769" @default.
• W2016287769 workType "article" @default.